DrugDashboards

Dronabinol

Dronabinol · DRONABINOL 5 mg/mL · Solution · Oral · Chartwell RX, LLC

NDC 62135-0033-43 · 1 BOTTLE, GLASS in 1 CARTON / 30 mL in 1 BOTTLE, GLASS · NDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application
NDA205525
TE code
Approval date
Mar 23, 2017
Patents / exclusivity
4 patents, 0 exclusivities
TypeNumber / codeExpires
patent10265293Aug 6, 2028
patent9345771Aug 6, 2028
patent11253472Aug 6, 2028
patent8222292Aug 6, 2028

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Dronabinol (Solution)

LabelerStrengthFirst seenLast seen
Wellhouse Pharma, LLCDRONABINOL 5 mg/mLJul 15, 2026Sep 3, 2026
Benuvia Operations, LLCDRONABINOL 5 mg/mLJul 15, 2026Sep 2, 2026
Chartwell RX, LLCDRONABINOL 5 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Dronabinol — NDC 62135-0033-43," retrieved September 3, 2026, https://drugdashboards.com/drug/62135003343.

Free to cite with attribution — see how the data is put together.